chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 7/24/00, pt noted red, raised rash on abdomen and chest, shoulder, upper back and behind both ears with tenderness two days ago. Developed "boil" in right inguinal area 4 days ago. Yesterday, broke open, with pus and bloody drainage. Applied antibiotic ointment and gauze. Sent to PMD and dx'd with Rubella and possible concurrent infection. No continuing problems. Was out of work X 7 days.
nurse who on 12JUN97 was exposed to varicella vaccine-while preparing vax for inj accidentally touched a drop of vax on finger  13JUN97 pt devel several water-filled vesicles on these two fingers, as well as itching;
Patient stated she started to have pain in her joints, and her ankle/leg was very swollen starting roughly 1 week after vaccine was administered. Patient stated the physician diagnosed it as a blot clot. Patient went to get a MRI done, which I do not know the results of at the moment. I reached out to the patient but I have not heard back yet.
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: occurred about 1 hour after patient left store after receiving vaccine,  mother gave benadryl, symptoms improved
pt recv vax 10JAN96 on 22JAN96 devel bell's palsy on rt side of face;seen by MD 25JAN96 MRI performed 31JAN96 was nl;spontaneous resolution occurred over approx 2 wk;
Received DTaP vaccine 2/13/2015. Mom reported that child developed hives 2/15/15. Child not evaluated by any medical professional for the rash.
Mom states she took child to ER with high fever over 104 and chills. We advised her to see a pediatrician to determine if it was from the shots or not on 9/17/03 when we were advised of the situation.
Feeling weak and tired, nauseas,  faint like, and continuous vomitting for an hour and a half immediately after receiving the shot, heavy breathing.
High dose of flu for those 65 years old and older given instead of normal dose for those 6 months and older.
Narrative:  66 YO M with PMH GERD, gout, HTN, ASCVD reported fatigue, fever, and injection site pain for approximately 24 hours following first dose of COVID vaccine on 2/9/21, which resolved without intervention. Patient received second dose of COVID vaccine on 3/2/21, has not reported any adverse reaction.
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a 14-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 20-Nov-2011. The patient received the expired FLUMIST on 29-Nov-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. The reporter stated that the patient did not experience any late occurring adverse events.
Right elbow became inflamed, red, warm and painful.  Right upper arm was sore.  Became dizzy at 11 AM on 3/2 and slept for 3 hours.  All expect the inflamed elbow were not a surprise.  I treated my elbow with an ice pack during the day on 3/2 and by 3/4 it had improved.  By 3/5 it was no longer inflamed, red or warm, but is still tender to lean on.  I informed my doctor's office of this.
Rash appeared on back of arms on 05/22/2014 along with redness at site of Kinrix. Throughout next 2 days rash spread to face arms back and then legs. No report of fever or itching. No other complaints. Mother took child to ER on 05/24/2014 and she was evaluated and told it probably was from immunizations but really not sure. She was placed on Orapred and mother states child cleared rash about 2 days later. Mother brought in ER visit progress notes along with pictures which is on file.
Patient presented to hospital on 06/08/2022 as a transfer from another Hospital for the management of Covid-19.  Patient developed progressive hypoxemic respiratory failure requiring hospitalization in the ICU.  She initially showed small improvement with dexamethasone and IV antibiotics, she ultimately developed worsened respiratory failure and oliguric renal failure.  Palliative care consulted.    On 06/21/2022 patient continue to decline and became unresponsive with worsened hypoxic respiratory failure.  MRI did not reveal acute change and encephalopathy was felt to be 2/2 respiratory failure.  Patient expired on 06/22/2022.
presented on 25JAN w/urticaria, fever 38.9C & myalgia
On 2/3/00, pt was given vaccines, within 24 hours, right thumb became swollen, had feeling of electrical shocks in thumb, joint clicking, complained of pain on movement. No prior history. Symptoms remain one month later.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. No information regarding the patient's medical history and concurrent conditions was provided. On 04-OCT-2016, the patient was vaccinated with an expired dose of PNEUMOVAX 23, lot # K010465, expiration date: 23-MAR-2016, intramuscularly, (dose, dose number and injection site were not provided). There were no concomitant medications reported. The pharmacist also stated that the patient reported vaccine "stung" at the time of vaccination. The patient did not seek medical attention. No laboratory diagnostic studies were performed. No treatment was given for the adverse event. No product quality complaint (PQC) was involved. The outcome of vaccine "stung" at the time of vaccination was unknown. The relatedness between the event and PNEUMOVAX 23 was not provided. Additional information has been requested.
pt recvd vax following delivery of baby on 30JAN93; approx 2 hrs later, exp progressive muscle weakness & lethargy; nurses reported that pt's sx were more profound than usual p/birth; hospitalization was prolonged;
HANDS SWELLED UP; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 20 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on JUL-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On JUL-2021, the subject experienced hands swelled up. On JUL-2021, the subject experienced headache. On JUL-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and the outcome of headache and hands swelled up was not reported. This report was non-serious.
bruising all through his left leg and calf; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruising all through his left leg and calf) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced CONTUSION (bruising all through his left leg and calf). At the time of the report, CONTUSION (bruising all through his left leg and calf) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge); This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the Reporter  No Treatment Medications were provided by the Reporter
Information has been received from a pharmacist via a field employee referring to an unspecified number of unknown age and gender. The patients' medical history included shingles, concurrent condition and concomitant therapy were not reported. On unknown dates, the patients vaccinated with ZOSTAVAX (dose, frequency, route, lot #, expiration date were unknown) which reconstituted with sterile diluent (lot# and expiration date unknown), for prophylaxis. The patients had large lumps around the injection site after the administration of ZOSTAVAX. It was unknown that if the patients had sought for medical attention. The outcome of the event was unknown at the time of this report. The relationship between the event and ZOSTAVAX or sterile diluent were not provided.
Breakthrough case admission after 2 vaccines Pfizer 1/26/21 lot# EL9264;  Pfizer 2/16/21 lot# EN6200
Patient received a vaccination with the Janssen brand on 07/28 and again on 08/06/21.
Headache, entire body aches especially joints, shivers and fever.  3 advils every 6-8 hours for the entire day.  Next day just exhausted and slow.  Thursday I was just about back to my normal self.
I had the Pfizer Booster shot.  I could not get up from bed, took me several attempts, could not control urine from leaking out, I could not absorb what I was reading, shuffling gait, sense of time lost (I had thought as of  yesterday, Dec 15,  that I had the vaccination done 4 days ago) . No treatment done.
c/o right upper arm tenderness 2 hrs post inj. R. (entire arm hurt-extending to fingers, c/o h/a 2 d. finger pain resolved.was unable to move R arm initially). Rx. - used cold packs, Vicodin and fentanyl patch and elevated R arm. No finger pain since 8/21 AM. As of 8/22 AM Right arm still hurts from elbow to injection site (10/10 pain scale).
Pt c/o swelling and warmth at injection site which began on day of injections then progressed to all over myalgia, subjective fevers, and malaise.
Nausea, sweating, headache for two day. Severe and persistent shoulder pain to the present day. Currently seeking medical treatment for adverse side effects.  The shot was given at the shoulder. Pain radiates from the injection site deep into the muscle.
Patient has allergies to several medications and keeps epipen on hand with her always. Was asked to sit for 30  minutes after vaccine. At minute 27 she started getting swelling and redness of her lips and face slightly. She normally takes Benadryl when this happens so gave her a Benadryl 50mg one dose. Her throat then became tight in a few minutes and she said that she needed an epipen because she was starting to have a little bit of trouble breathing. Gave epipen and her symptoms resolved within a few minutes. Kept her for 15 minutes. She stated that she knew she would be ok and asked if she could leave. I stated she needed to see the ER if she had any more trouble. I also consulted with her to check with her doctor about getting the 2nd dose because more than likely it's not recommended.
Child was given vaccine combination Pediatrix ( DTAP-Hepatitis B- IPV ) along with a 2nd dose of IPV single dose IM -Sanofi Lot # VB901M . Hepatitis B #3 was too early  . Child received 2 doses of IPV . Same day child was given on schedule Rotavirus (Rota-Teq) Prevnar 13.
This initial spontaneous report was received on 11-SEP-2018 from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 07-JAN-2012, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 23-JAN-2015, the patient was treated at a medical center for the onset of a severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
pt recvd vax & w/in 1 wk following vax pt exp hives;
48 hrs after vaccine administered had swelling, redness, tender.  To RTR- 2" by 2" - raised red & swelling to L deltoid- 15mm by 15mm diffuse red.
exposure to hep B vax-pt mom holding child who was moving a lot & the needle & syringe separated & some vaccine went into mom's eye;mom was ok when left clinic p/being checked by MD;that noc 9PM mom to ER w/diff breathing & rash & swelling;
Narrative: 89 year old male admitted on August 11 2022 with chills, productive cough, and fever with mild hypoxia. He had received Moderna vaccine x 4 on January 21 2021, February 17 2021, August 31, 2021, May 4 2022. He was treated with remdesivir 200 mg x 1 then 100 mg daily x 3 days and dexamethasone 6 mg IV x 5 days. He clinically improved and was discharged home on 8/16/2022.
eye redness; chronic eye tearing; eye soreness; eye itchiness; swollen eyes and eyelids; swollen eyes and eyelids; waking up with eyes crusty; dry eyes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04May2021 at 10:00 as dose 2, single (Lot number: EW0171) at the age of 55 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "hypothyroidism" (unspecified if ongoing); "Highly allergic to shellfish" (unspecified if ongoing); "pollen allergy/grass pollen allergy" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; ARMOUR THYROID. Past drug history included: Erythromycin, reaction(s): "Known allergies: erythromycin". Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EW0161, Administration time: 10:00 AM, Vaccine location: Left arm), administration date: 13Apr2021, when the patient was 55-year-old, for COVID-19 Immunization. The following information was reported: LACRIMATION INCREASED (non-serious) with onset 17May2021 at 06:00, outcome "not recovered", described as "chronic eye tearing"; DRY EYE (non-serious) with onset 17May2021 at 06:00, outcome "not recovered", described as "dry eyes"; EYE PRURITUS (non-serious) with onset 17May2021 at 06:00, outcome "not recovered", described as "eye itchiness"; OCULAR HYPERAEMIA (non-serious) with onset 17May2021 at 06:00, outcome "not recovered", described as "eye redness"; EYE PAIN (non-serious) with onset 17May2021 at 06:00, outcome "not recovered", described as "eye soreness"; EYE SWELLING (non-serious), SWELLING OF EYELID (non-serious) all with onset 17May2021 at 06:00, outcome "not recovered" and all described as "swollen eyes and eyelids"; EYELID MARGIN CRUSTING (non-serious) with onset 17May2021 at 06:00, outcome "not recovered", described as "waking up with eyes crusty". The events "eye redness", "chronic eye tearing", "eye soreness", "eye itchiness", "swollen eyes and eyelids", "waking up with eyes crusty" and "dry eyes" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of ocular hyperaemia, lacrimation increased, eye pain, eye pruritus, eye swelling, swelling of eyelid, eyelid margin crusting, dry eye.  Additional information: Two weeks after receiving her second Pfizer COVID-19 vaccine, the patient began experiencing eye issues that she had not experienced in her entire life, including: chronic tearing, soreness, itchiness, swollen eyes and eyelids, and waking up with eyes crusty. The patient received eye drops for dry eyes and allergy medications. She stated she had never had eye issues. The patient received her third Pfizer COVID-19 monovalent vaccine on 03Jan2022 at 10:00 AM in the left arm.
pt recv vax 30SEP96 & 21APR97 pt devel chickenpox consisting of approx 50 lesions;30APR97 pt recovered;
I received the shot at 12:30 pm and stayed 30 mins to see if I had any reaction. I felt fine. Left stadium at 1 pm. On the way home, at 1:15pm I started feeling sharp pin pricks in my right ring finger. Over the course of the next few hours, both arms from shoulder to fingers, had a pins and needles feeling, was extremely itchy, and heat exacerbated the symptoms. Lasted in intensity for about a week.  I still have the pins and needles sensation, but it?s much less in intensity- more of a dull vibration, and is primarily from elbow to fingers.
I felt very heavy (especially my limbs) and had a slight headache on Thursday (the day after receiving the vaccine).  This feeling continued into Friday morning when I nearly passed out (blacked out and collapsed for a split second) as I was crouched position for approximately 10 minutes at work.  I felt dizzy and slow moving for the next several hours.  My blood pressure was rated as normal, blood oxygen normal, and pulse slightly low by a nurse on staff who took my vitals after the episode.   My temperature, which had been 97.8 prior to the event that morning (typical for me) was elevated during this time to 100.2 and returned to normal after approximately 4 hours without medication.  I was fatigued, so I slept for approximately 4-5 hours that afternoon and began feeling better the following day (Saturday).
Left arm - swelling. Involving slightly more than 1/2 of the arm and extending to nearly 50% of the circumference.
vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037KZ0A) for COVID-19 vaccination.     Concurrent medical conditions included Pregnant. Concomitant products included VITAMINS NOS.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 06-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). On 06-Jan-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021.
Within 2 hours of receiving vaccination, pt developed itching, and then a generalized rash, including throat itching & swelling.
Pinched nerve at injection site with symptoms that began approximately 72 after COVID-19 vaccine administration.
ARM HURTING FOR A WEEK; FEVER; NAUSEOUS; MAJOR HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced arm hurting for a week, fever, nauseous, and major headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, nauseous, and major headache, and had not recovered from arm hurting for a week. This report was non-serious.
Narrative:  80yo male with hx of Multiple Myeloma treated at facility outside of our facility died at home on 6/29/2021. Pt had received covid-19 vaccines EUA on 2/1/21 & 3/9/2021. Appears death is not related to vaccinations.
Problem was not with vaccine, or the four subsequent vaccines; simply got Covid months after last booster which was administered on 7-26-22